|
24(S)-Hydroxycholesterol
- 英文名称:24(S)-Hydroxycholesterol
- 品牌:WYTSCI
- 产地:进口
- 型号:1MG
- 货号:WT-AY-B10238
- cas:474-73-7
- 价格: ¥1/mg
- 发布日期: 2025-04-10
- 更新日期: 2025-12-08
产品详请
| 产地 | 进口 |
| 品牌 | WYTSCI |
| 货号 | WT-AY-B10238 |
| 用途 | 科研检测 |
| 英文名称 | 24(S)-Hydroxycholesterol |
| 包装规格 | 1MG |
| CAS编号 | 474-73-7 |
| 别名 | 24(S)-Hydroxycholesterol |
| 纯度 | 98+% |
| 分子式 | |
| 是否进口 | 是 |
纯度:99% by HPLC,;NMR (Conforms)
分子式:C27H46O2
分子量:402.66
溶剂:DMSO (10 mg/ml) Ethanol (10 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):Endogenous cholesterol metabolite
Function / Pharmacology:24(S)-Hydroxycholesterol is an important cholesterol metabolite (cholesterol 24-hydroxylase) found in the brain.1 It is an endogenous agonist of the nuclear receptor LXR.2 It has been shown to induce cell death in neuroblastoma cells3, possibly via a necroptosis pathway4. 24(S)-Hydroxycholesterol has also been found to be a high affinity ligand for RORα and RORγ (Ki = 25 nM).5 24(S)-Hydroxycholesterol levels are elevated in the cerebral spinal fluids of patients with neurogenerative diseases suggesting possible clinical applications.6,7 It was also able to reduce Aβ production and increase ER-resident immature amyloid precursor protein (APP) levels in human neuroblastoma SH-Sy5Y cells and CHO cells via inhibition of intracellular amyloid precursor protein trafficking.7
分子式:C27H46O2
分子量:402.66
溶剂:DMSO (10 mg/ml) Ethanol (10 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):Endogenous cholesterol metabolite
Function / Pharmacology:24(S)-Hydroxycholesterol is an important cholesterol metabolite (cholesterol 24-hydroxylase) found in the brain.1 It is an endogenous agonist of the nuclear receptor LXR.2 It has been shown to induce cell death in neuroblastoma cells3, possibly via a necroptosis pathway4. 24(S)-Hydroxycholesterol has also been found to be a high affinity ligand for RORα and RORγ (Ki = 25 nM).5 24(S)-Hydroxycholesterol levels are elevated in the cerebral spinal fluids of patients with neurogenerative diseases suggesting possible clinical applications.6,7 It was also able to reduce Aβ production and increase ER-resident immature amyloid precursor protein (APP) levels in human neuroblastoma SH-Sy5Y cells and CHO cells via inhibition of intracellular amyloid precursor protein trafficking.7



